SEC Filing Details

Document Details

Form

Filing Date

Oct 16, 2024

Document Date

Oct 14, 2024

Form Description

Initial filing by director officer or owner of more than ten percent

Filing Group

3,4,5

Company

MaxCyte Inc

Issuer

MAXCYTE, INC.

Filer

Collins Cynthia

View HTML

ATx

From small to medium static Electroporation.

STx

Transfect up to 20 billion cells with scalable static or flow-through electroporation.

GTx

Transfect up to 20 billion cells with our clinically validated and cGMP compliant flow-through electroporation.

VLx

For gram scale protein production.

Processing Assemblies

Achieve the desired scale and throughput with a range of consumable devices.

Reagents & Supporting Products

Complement your workflow with our flexible electroporation buffer formats and accessories.